We have previously demonstrated that interrupting the protein-protein interaction (PPI) of b-tubulin:chaperonin-containing TCP1b (CCT-b) induces the selective killing of multidrug-resistant cancer cells due to CCT-b overexpression. However, the molecular mechanism has not yet been identified. In this study, we found that CCT-b interacts with a myriad of intracellular proteins involved in the cellular functions of the endoplasmic reticulum (ER), mitochondria, cytoskeleton, proteasome and apoptosome. Our data show that the targeted cells activate both the heat-shock protein 90 (Hsp90)-associated protein ubiquitination/ degradation pathway to eliminate misfolded proteins in the cytoplasm and the valosin-containing protein (VCP)-centered ERassociated protein degradation pathway to reduce the excessive levels of unfolded polypeptides from the ER, thereby mitigating ER stress, at the onset of b-tubulin:CCT-b complex disruption. Once ER stress is expanded, ER stress-associated apoptotic signaling is enforced, as exhibited by cellular vacuolization and intracellular Ca 2 þ release. Furthermore, the elevated intracellular Ca 2 þ levels resulting from capacitative Ca 2 þ entry augments apoptotic signaling by provoking mitochondrial perturbation and caspase overactivation in the targeted cells. These findings not only provide a detailed picture of the apoptotic signaling cascades evoked by targeting the b-tubulin:CCT-b complex but also demonstrate a strategy to combat malignancies with chemoresistance to Hsp90-and VCP-related anticancer agents. Chaperonin-containing TCP-1 (CCT) is a hetero-oligomeric ring complex composed of eight subunits (a, b, g, d, e, z, Z, and y).
to activate Hsp90-and VCP-dependent UPS rapidly to mitigate ER stress. 11, 12 This I-Trp-induced perturbation of the protein networks originating from the disruption of btubulin:CCT-b complexes apparently triggers both protein degradation systems, thereby forcing target cells towards ER stress-associated apoptosis. In this pathway, the elevated intracellular Ca 2 þ levels and mitochondrial destruction ultimately converge to overactivate the caspases involved in apoptosis. This report is the first to describe the apoptotic mechanism evoked by targeting the b-tubulin:CCT-b complex. Furthermore, this mechanism provides insight into the PPI of CCT-b with Hsp90 and VCP, which both represent potential anticancer targets. 13, 14 Results CCT-b is crucial for I-Trp-induced cell apoptosis. Using mass spectrometric analysis, we have previously found that I-Trp binds to b-tubulin by alkylating the Cys 354 residue, thereby disrupting the b-tubulin:CCT-b complex and inducing cell apoptosis. 10 However, the detailed molecular mechanism remains unclear ( Figure 1a ). To confirm whether the alkylation of residue Cys 354 is the key step for interrupting the PPI of the b-tubulin:CCT-b complex and inducing apoptosis, we generated variant human embryonic kidney (HEK)-293 cell lines that stably express exogenous plasmids either without (mock) or with DNA encoding either wild-type (wt) or mutant (C354S) b-tubulin. The HEK-293 cells were selected because they express high levels of the b-tubulin and CCT-b proteins (Supplementary Figure 1) and are thus highly sensitive to I-Trp. 10 Western blot analysis revealed that btubulin levels were relatively abundant in HEK-293 cells expressing either wt or C354S b-tubulin compared with the control cells, whereas the CCT-b expression levels were comparable among the three variants (Figure 1b 
. Similar results were also observed in the MDR MES-SA/Dx5 cells. 10 Unlike the results obtained with tubulin-binding agents (e.g., PTX), our data demonstrate that the binding 10 These data indicate that CCT-b might have a crucial role in mediating I-Trp-induced apoptosis once the b-tubulin:CCT-b complex is disrupted. Therefore, we next assessed the involvement of CCT-b-associated proteins in cell apoptosis induced by disrupting the b-tubulin:CCT-b complex.
Identification of intracellular CCT-b-associated proteins. To isolate the proteins constitutively associated with CCT-b, we first purified N-terminal His-tagged CCT-b recombinant protein as the bait (Supplementary Figure 3a) . Next, we performed immunoprecipitation analysis to validate the binding ability of the His-tagged CCT-b protein with its protein substrate, b-tubulin, in vitro (Supplementary Figure 3b) . Based on these results, we performed a pulldown experiment with recombinant CCT-b protein with cell lysates derived from HEK-293, parental MES-SA or MDR MES-SA/Dx5 cells, and subsequently analyzed the proteins that were pulled down by electrophoresis (Supplementary Figure 3c) . We excised the major protein bands, as indicated from the gel, and examined them via mass spectrometric analysis (Supplementary Figure 3c) . Using Mascot software to analyze the mass spectrometric data against the NCBI human protein database, we identified several proteins (Figure 2a ) that may be associated with CCT-b. As expected, the cytoskeleton proteins, actin and tubulin, which are both well-known protein substrates of CCT and capable of interacting with CCT-b, were identified from protein band B. With protein band A, we found Hsp90 and its homologous proteins, tumor necrosis factor type 1 receptor-associated protein and tumor rejection antigen (gp96), which are located in the mitochondria and ER, respectively. These proteins are referred to as chaperones or stress proteins because they exhibit a critical function in assisting newly synthesized polypeptides (clients) in achieving functional conformation, localization, activation and oligomerization. 17 The proteasome subunit p26, which participates in the cytoplasmic UPS and is responsible for the proteolytic degradation of misfolded proteins, 18 was also identified from protein band B. VCP, which has a critical role in ER-associated protein degradation (ERAD) machinery and couples with its cofactors, Ufd1-Npl4, to dislodge misfolded/polyubiquitinated proteins, including misfolded Hsp90 clients, by a retrotranslocation model from the ER into the cytoplasm for degradation by the UPS in response to ER stress, 19 was identified from protein band A. With protein band B, we identified SPFH-1, which is a recognition protein of the inositol 1,4,5-trisphosphate (IP 3 ) receptors, forms tetrameric calcium channels in the ER membrane, controls the release of ER Ca 2 þ stores and intimately associates with VCPcentered ERAD machinery to regulate the protein degradation of IP 3 receptors expressed on the ER membrane. 20 The protein translational regulators, eukaryotic translation elongation factor 2 (EEF2) and S3 ribosomal protein, were also identified from protein bands A and C, respectively. Interestingly, in protein band B, we identified X-linked inhibitor of apoptosis protein (XIAP), which exerts antiapoptotic effects by confining active caspase-3, caspase-7 and caspase-9, 21 and is capable of relieving ER stress-induced apoptosis. 22 Moreover, caspase-7, which is one of executioner caspases involved in the demolition phase of apoptosis 23 and has been considered to be closely associated with ER stress-induced apoptosis, 24 was found in protein band C. To confirm the results obtained from the mass spectrometric analysis, we performed immunoblotting to detect Hsp90, VCP, XIAP and caspase-7 using the corresponding antibodies in the mixture of proteins identified in the CCT-b pull-down with HEK-293, MES-SA or MES-SA/Dx5 cells. Our data revealed that CCTb is probably constitutively coupled with these proteins in the target cells (Figure 2b ). To understand further the PPI of CCT-b with the identified proteins in the public domains, we performed a network assessment of CCT-b using the Ingenuity Pathway Analysis (IPA) (http://www.ingenuity. com). The results demonstrated that CCT-b directly interacts with the b-subunits of actin and tubulin and indirectly affects both Hsp90-and VCP-related proteasome activities. Moreover, CCT-b was shown to couple with the ER system via a connection with the EEF2 pathway (Figure 2c ). Although the IPA results did not support the hypothesis that CCT-b directly interacts with XIAP and caspase-7, the activation of the proteasome due to the destruction of the b-tubulin:CCT-b complex may trigger the proteolysis of XIAP, thereby relieving XIAP inhibition of caspase-7 activity during cell apoptosis.
Overall, in the resting stage, CCT-b probably interacts with molecules that have a role in assisting protein assembly, eliminating misfolded proteins via the UPS or ERAD machinery and governing ER functions. Therefore, we proposed the hypothesis that targeting the b-tubulin:CCT-b complex with I-Trp presumably interferes with the PPI of CCT-b with those molecules, which might sequentially activate Hsp90-and VCP-associated UPS activities and provoke an ER stressdependent cell apoptosis in the target cells.
Destruction of the b-tubulin:CCT-b complex provokes Hsp90-dependent protein ubiquitination and degradation. To test our hypothesis, we examined whether Hsp90 chaperone activity is altered in response to I-Trp stimulation. It has been shown that Hsp90 collaborates with Hsp70 and other co-chaperones to assist protein folding of its clients or convey misfolded/ubiquitinated proteins to the UPS for terminally proteolytic degradation. 17 Recently, this Hsp70/ Hsp90 protein folding complex was reported to interact with the CCT multi-subunit complex via an interaction with its bsubunit, CCT-b. 25 To understand the role of Hsp90 in the cellular apoptosis induced by the b-tubulin:CCT-b complex destruction, we generated an Hsp90 knockdown variant using HEK-293 cells. Remarkably, silencing Hsp90 expression (Figure 3a Interrupting the b-tubulin:CCT-b complex recruits the VCP-centered ERAD machinery. We next determined whether the VCP-centered ERAD pathway is recruited in response to I-Trp stimulation. It has been shown that VCP is required for extracting unfolded/misfolded proteins from the ER to mitigate ER stress 27 and that loss of VCP function or expression consequently leads to an ER stress-dependent cell apoptosis. 28 Therefore, we artificially overexpressed VCP in HEK-293 cells (Figure 4a Figure 4 ). These findings demonstrate that the VCP-centered ERAD pathway is indeed activated but might be overloaded in the event of counteracting the elevated ER stress, due to the deposition of unfolded proteins that resulted from the I-Trp-induced disruption of the b-tubulin:CCT-b complex. As ER stress is continuously expanded, the targeted cells might be committed to ER stress-associated apoptosis. Caspase overactivation in the event of b-tubulin:CCT-b destruction. We have previously demonstrated that the destruction of the b-tubulin:CCT-b complex elicits the overactivation of intracellular caspases, except caspase-1, thereby inducing cellular apoptosis. 10 As intracellular Ca 2 þ release has been shown to be essential for caspase-3 and caspase-9 activation, 34 we next attempted to delineate the effect of intracellular Ca cells. We treated the cells with TG to induce an intracellular Ca 2 þ release directly and subsequently examined the intracellular caspase activity. The activity levels of initiator caspases, caspase-2, caspase-4, caspase-5, caspase-8 and caspase-10, as well as the effector caspases, caspase-3 and caspase-7, were significantly increased, while the activity level of initiator caspase-9 was slightly elevated in the TGtreated HEK-293 cells (Figure 6a) . However, the activity levels of the effector caspase-6 and caspase-1 were not detectable throughout the TG administration in HEK-293 cells (Figure 6a ). The pharmaceutical inhibition of intracellular Ca 2 þ release with DTL exhibited a dosedependent reduction in the activity levels of the initiator caspases, caspase-4, caspase-5, caspase-8 and caspase-10, induced by I-Trp treatment (Figure 6b ). These data reveal that the elevated intracellular Ca 2 þ levels have an important role in the activation of the caspase family during I-Trpinduced cell apoptosis. 
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35 or upon the activation of caspase-8 36 and is critical for triggering the intrinsic caspase-9-dependent apoptotic pathway. Therefore, we next examined whether mitochondrial perturbation takes place in I-Trp-treated HEK-293 cells. The data show that treatment with I-Trp altered the mitochondrial membrane potential (Figure 7a ) and induced cytochrome c release from the mitochondria to the cytoplasm in a dose- (Figure 7b ) and time- (Figure 7c ) dependent manner. Fluorescent immunocytological staining revealed that treatment with I-Trp caused mitochondrial disruption and cytochrome c release (Figure 7d ). Silencing CCT-b expression predominantly abolished cytochrome c release from the mitochondria in I-Trp-treated cells (Figure 7e) . Accordingly, the inhibition of intracellular Ca 2 þ release with DTL ( Figure 7f ) and inhibition of caspase-8 activity with its peptide inhibitor, IETD (Figure 7g ), markedly suppressed cytochrome c release from the mitochondria. These findings indicate that I-Trp-induced ER Ca 2 þ release and caspase-8 activation modulate mitochondrial perturbation and cytochrome c release, which might, in turn, trigger intrinsic caspase-9-dependent caspase activation during cell apoptosis in the target cells.
Discussion
In this study, we show that disrupting the intracellular b-tubulin:CCT-b complex with I-Trp by alkylating the Cys 354 residue of b-tubulin activates the Hsp90/UPS pathway to elicit cellular proteolysis; however, this disruption probably impedes the protein trafficking of Hsp90 clients (e.g., b-tubulin 26 ) from the ER compartment to the CCT complex, 25 thereby promoting the accumulation of unfolded proteins in the ER compartment and amplifying ER stress. Although the VCP-centered ERAD pathway is concurrently activated to extract unfolded proteins from the ER to mitigate the elevated ER stress, ER stress-associated cell apoptosis is eventually enforced in the target cells. The Ca 2 þ release from the ER is likely to be crucial for relaying I-Trp-induced ER stressassociated cell apoptosis, as the elevated Ca 2 þ levels via the capacitative Ca 2 þ entry model are required to trigger mitochondrial perturbation, cytochrome c release and caspase overactivation (Figure 8 ).
Hsp90 expression has been found to correlate with tumorigenesis and cancer progression, 37, 38 and the protein serves as novel chemotherapeutic target for cancer therapy.
14 Therefore, compromising Hsp90 function with the corresponding inhibitors, such as GA and tanespimycin (17-AAG), has become a promising anticancer strategy to combat certain malignances. 39, 40 However, acquired chemoresistance of the Hsp90 inhibitors, GA and tanespimycin, has been observed in cultured cancer cells with increased levels of the cystine-glutamate transporter SLC7A11 41 and reduced expression of NAD(P)H/quinone oxidoreductase 1, 42 respectively. Therefore, it has become an urgent matter either to modify known Hsp90 inhibitors or to discover new Hsp90 inhibitors to overcome chemoresistance. Alternatively, targeting the PPI of CCT-b with its substrates (e.g., b-tubulin) may represent a more promising strategy to overcome chemoresistance of Hsp90 inhibitors, as Hsp90 acts as a downstream effector of CCT-b signaling. This concept is supported by microarray analysis displaying that CCT-b mRNA levels in tanespimycin-resistant cancer cell lines are significantly higher than those in tanespimycin-sensitive cells (Supplementary Figure 6) .
Recently, the upregulation of VCP expression has been observed in clinical tumors and correlates with both cancer progression and the poor prognosis of cancer patents. 43, 44 Moreover, the induction of VCP proteolysis 45 or inhibition of its ATPase activity 13, 46 has also been recommended as new chemotherapeutic strategy for cancer therapy. In this study, our data show that the combination of I-Trp and the VCP inhibitor exhibits synergistically cytotoxic effects on the target cells, thereby providing evidence of a PPI inhibitor of the b-tubulin:CCT-b complex in cancer treatment using VCP inhibitor-based chemotherapy. Notably, the understanding of VCP regulation in the targeting of the b-tubulin:CCT-b complex sheds light on the mechanism of overcoming the inefficiency (e.g., chemoresistance) of VCP-targeted chemotherapy.
PTX, an anticancer tubulin-binding agent, targets b-tubulin to impede microtubule dynamics and thereby inhibits tumor growth. 15 However, the alteration of b-tubulin subtype expression, 47, 48 10 we have also developed a drug-like small-molecule PPI inhibitor that binds reversibly to b-tubulin in the interface with CCT-b and triggers cell apoptosis via the same mechanism (our unpublished data). Our study therefore unveils signaling pathways useful for developing novel anti-MDR cancer chemotherapy. In summary, targeting the b-tubulin:CCT-b complex elicits ER stress-associated apoptosis via Ca 2 þ -dependent mitochondrial perturbation and caspase overactivation. These findings also represent an advance in the understanding of the PPI of CCT-b with Hsp90-dependent and VCPcentered protein trafficking/degradation systems and the XIAP/caspase-7-associated apoptosome, which may provide an alternative option to overcome chemoresistance to Hsp90-and VCP-targeting anticancer agents.
Materials and Methods
Materials. All chemicals used for organic synthesis were purchased from Aldrich-Sigma (St. Louis, MO, USA). MitoTracker and Fura-2-AM were purchased from Invitrogen (Carlsbad, CA, USA). Protein A-agarose; antibodies against b-tubulin, b-actin, CCT-b, cytochrome c and Hsp90; siRNA for VCP; and shRNA for CCT-b and Hsp90 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against VCP, ubiquitin and GAPDH were purchased from Cell Signaling (Danvers, MA, USA). TG, DTL and BAPTA were purchased from Calbiochem (San Diego, CA, USA). Mitochondrial membrane potential detection kits were obtained from BD Biosciences (San Jose, CA, USA). Caspase and proteasome activity assay kits, GA and the caspase-8 inhibitor were purchased from BioVision (Mountain View, CA, USA). The VCP inhibitor (patent no: CIT-5066) was generously provided by Dr. Chou TF at the California Institute of Technology (Pasadena, CA, USA).
Cell culture. All cell lines used in this study were obtained from the Bioresource Collection and Research Center in Taiwan. HEK-293 cells were cultivated in MEM supplemented with 10% fetal bovine serum (FBS) and 250 U/ml of penicillin/streptomycin solution. MES-SA and MES-SA/Dx-5 uterine cancer cells were cultivated in McCoy's 5A medium supplemented with 10% FBS and 250 U/ml of penicillin/streptomycin solution. All cell culture media and supplements were purchased from Gibco (Invitrogen). The cells were maintained in the presence of 5% CO 2 at 37 1C.
Plasmid construction and protein expression. The genes encoding CCT-b (NM_006431.2), b-tubulin (NM_006087.2) and VCP (NM_007126.2) were amplified from human cDNA (Invitrogen) using the standard or sticky-end polymerase chain reaction (PCR) procedure with paired primers (See Supplementary Table 1 ) and subcloned into either the pET32-Xa/LIC (for CCTb) or pIRES2-EGFP (for b-tubulin and VCP) vectors, respectively. The pIRES2-EGFP/b-tubulin plasmid was used as a DNA template for site-directed mutagenesis of the Cys 354 residue to Ser. The PCR reaction was performed using paired primers (see Supplementary Table 1 ) and a Pfu polymerase kit (Stratagene, Cedar Creek, TX, USA). The PCR products were treated with Dpn1 endonuclease (New England BioLabs, Ipswich, MA, USA) to digest the methylated parental DNA template. The identities of individual clones were verified via doublestrand plasmid sequencing.
Recombinant CCT-b was overexpressed in the Escherichia coli strain BL-21(DE3) as a C-terminal hexa-His-tagged protein. To generate stable cell lines, HEK-293 cells were transfected for 24 h with pIRES2-EGFP plasmid DNA with or without either b-tubulin or the VCP gene at 1 mg using the Lipofetamine delivery system (Invitrogen). After selection with G418 antibiotic, cells were seeded in 96-well plates at a density of 5 cells per ml to yield a single colony per well. Cells stably expressing either the b-tubulin or VCP constructs were monitored by EGFP expression.
Protein purification. Protein purification was performed at 4 1C. Cell pellets obtained from a 2-l culture of the E. coli strain BL-21(DE3) were resuspended in 80 ml buffer A (12 mM Tris-HCl (pH 7.5) and 120 mM NaCl). A French pressure cell (AIM-AMINCO Spectronic Instruments, Lake Forest, NY, USA) was used to disrupt the cells at 12 000 psi. Cell lysates were centrifuged at 25 000 Â g at 4 1C. Supernatants were loaded onto a 20 ml Ni-NTA resin that was equilibrated with buffer A. The column was washed with excess buffer A containing 10 mM imidazole. His-tagged CCT-b was eluted with buffer B (12 mM Tris-HCl (pH 7.5), 120 mM NaCl and 300 mM imidazole). The eluted protein solution was dialyzed with 2 Â concentrated buffer A at 4 1C overnight.
siRNA transfection and lentivirus-driven shRNA infection. Cells (50% confluence) grown in 6-well plates were transfected with either control or VCP siRNA at 100 nM for 24 h before observing cellular vacuolization or bathed in fresh media containing 5 mg/ml of polybrene (Santa Cruz Biotechnology) before infection with a lentiviral viral particle-driven control, CCT-b or Hsp90 shRNA overnight. To select cells stably expressing the control, CCT-b or Hsp90 shRNA, cells were cultivated in the presence of puromycin (10 mg/ml) for 24 h. The puromycin-resistant cells were subsequently split into 96-well plates at a density of 1 cell per well to generate a cell line stably expressing the control, CCT-b or Hsp90 shRNA.
Preparation of cytosolic and mitochondrial fractions. Cells were collected in 1 ml hypotonic HEPES buffer (10 mM HEPES (pH 7.4), 5 mM MgCl 2 , 40 mM KCl and 4% protease inhibitor cocktail (Merck Biosciences, San Diego, CA, USA)) and placed on ice for 30 min. Cell suspensions were passed through a 27-G needle-containing syringe 25 times before the centrifugation at 1000 Â g for 20 min. The supernatants were further centrifuged at 10 000 Â g for 30 min to separate the cytosolic fractions (supernatants) from the mitochondrial fractions (pellets).
Western blotting. The cell lysates (100 mg) were boiled for 5 min in SDS sample buffer (62.5 mM Tris-HCl (pH 6.7), 1.25% SDS, 12.5% glycerol and 2.5% b-mercaptoethanol) and the proteins were separated via SDS-PAGE. For western blotting, proteins were transferred onto a PVDF membrane (Millipore, Billerica, MA, USA) and incubated with an antibody against ubiquitin, b-tubulin, CCT-b, Hsp90, VCP, cytochrome c, GAPDH or b-actin. After incubation with horseradish peroxidase-conjugated secondary antibody, immunoreactive protein bands were visualized using the enhanced chemiluminescence system (Amersham Bioscience, Tokyo, Japan).
RT-PCR. Total RNA was extracted from cells using a RNA extraction kit (Genomics, Taipei, Taiwan). Aliquots (5 mg) of total RNA were treated with M-MLV reverse transcriptase (Invitrogen) and then amplified with Taq polymerase (MDBIO, Beijing, China) using paired primers as shown in Supplementary Table 1.
Apoptosis assessment. Cells (6 Â 10 5 ) were fixed in 70% ice-cold EtOH for 30 min at RT. Cells were washed with PBS once and were incubated with propidium iodide (PI) staining solution (PBS containing 0.1% BSA, 0.1% RNase A and 20 ng/ml PI) for 30 min at RT in the dark. After the incubation, the cells were analyzed by flow cytometry to assess their DNA content. Cells accumulated in the sub-G0 region were defined as apoptotic cells because we have verified that the cytotoxic effects of I-Trp on HEK-293 cells is via apoptotic cell death, as determined by DNA fragmentation. 10 Determination of proteasome activity. After being treated with I-Trp (5 mM) for designated time periods, cells were collected and resuspended in cell lysis buffer (BioVision). Aliquots of cell lysates (50 mg) were incubated with 1 mM of fluorescent proteasome substrate (BioVision) for 30 min at 37 1C. The fluorescent intensity was read using a fluorimeter with an exciting wavelength at 355 nm and emission wavelength at 405 mm and presented as relative proteasomal activity. Figure 2c) were excised from the gel and subject to in-gel tryptic digestion and liquid chromatography-electrospray ionization-tandem mass spectrometric analysis. The raw data were converted to the Mascot (Matrix Science) generic format and analyzed using the NCBInr human protein database.
Calcium image. Cells were seeded on poly-L-lysine-coated round cover slides (22 mm in diameter and 0.17 mm in thickness). After a 2-day culture, cells were pre-incubated with 4 mM Fluoro-3 dye at 37 1C for 30 min. After incubation, cells were transferred to a slide chamber containing 0.4 ml Hank's balanced saline solution and examined using a confocal microscope (Olympus, Tokyo, Japan) with an argon laser (488 nm). After adjusting the proper field, I-Trp (5 mM) was carefully added into the slide chamber, and the changes in intracellular Ca 2 þ levels were observed.
Measurement of intracellular calcium. Cells were cultured in 6-well culture plates containing poly-L-lysine-coated 9 Â 220 mm 2 cover slides. After a 2-day culture, cells were pre-treated with 5 mM Fura-2-AM for 30 min at 37 1C. Subsequently, each cell-grown cover slide was transferred into a 4-ml quartz cuvette containing 2 ml focal buffer (10 mM HEPES, 140 mM NaCl, 5 mM KCl and 2.6 mM D-glucose). The analysis of the intracellular calcium oscillation was performed using a Hitachi F-4500 Fluorescence Spectrophotometer with the Intracellular Cation Measurement System (Hitachi, Tokyo, Japan). A designated amount of I-Trp (5 mM), IDAM (5 mM) or TG (1 mM) was added using a microinjection syringe when the baseline (380 nm) was stable. The levels of intracellular calcium are presented by the ratio of 340-to 380-nm excitation wavelength-induced fluorescent intensities emitted at 510 nm.
Determination of the mitochondrial membrane potential. HEK-293 cells (5 Â 10 6 ) were collected post-treatment with or without I-Trp (5 mM) for 2 h at 37 1C and stained with JC-1 working solution (BD Biosciences) for 15 min at RT. After washing the cells with assay buffer (BD Biosciences) two times, the cells were resuspended in 0.5-ml assay buffer and analyzed via flow cytometry. JC-1 is a lipophilic fluorochrome that is used to evaluate the status of the membrane potential (Dc) and driven into the mitochondria by Dc. JC-1 is rapidly taken up by the cell and forms aggregates within the healthy mitochondria. The aggregates can be detected in the red (FL-2) channel on the flow cytometer. In contrast, JC-1 does not accumulate within the mitochondria with depolarized Dc and remains in the cytoplasm as monomers and therefore displays a reduced fluorescence in the FL-2 channel.
Confocal microscope observation. Cells (1 Â 10 5 /ml) cultivated on cover slides (22 mm in diameter and 0.17 mm in thickness) were fixed in 4% formaldehyde for 15 min at RT. After washing cells two times with PBS, the cells were treated with 95% EtOH/5% CH 3 COOH at À 20 1C for 15 min. Before blocking with 2% BSA/0.1% Triton X-100 for 2 h at RT, the cells were washed two times with PBS. Subsequently, the cells were incubated with cytochrome c antibody overnight at 4 1C. After washing the cells three times with PBS, the cells were incubated with biotin-conjugated secondary antibody (DAKO, Glostrup, Denmark) for 1 h at RT. The cells were washed three times with PBS and incubated with fluorescein-conjugated avidin complex (Vector Laboratories, Peterborough, UK) for 30 min at RT. For mitochondrial staining, cells were incubated with MitoTracker (Invitrogen) for another 15 min at RT. After mounting the cells with a commercial kit containing DAPI reagent (Vector Laboratories), the cells were analyzed using a FluoView confocal microscope system (Olympus).
Determination of caspase activity. The caspase activity assay was performed according to the manufacturer's guidelines (BioVision). Briefly, cell lysates (200 mg) were diluted in 50 ml of cell lysis buffer (supplied by the kit). Equal volumes of the 2 Â reaction buffer (supplied by the kit) containing 10 mM DTT were added to the cell lysates. Subsequently, 50 mM of fluorescent dye-conjugated caspase substrate was individually added to the designated caspase activity assay. After a 2-h incubation, free fluorescent dyes in the solution were read in a fluorimeter equipped with a 385-and 510-nm emission filter. Fold increases in caspase activity were determined by comparing these results with the level of the untreated control.
Statistical analysis. In this study, statistical analysis of three independent experiments was performed using the non-parametric Mann-Whitney test. All statistical tests were two-sided, and Po0.05 was considered to be significant (*Po0.05, **Po0.01 and ***Po0.001).
